Oral delivery of anticancer drugs III: formulation using drug delivery systems

被引：76
|
作者：
Mazzaferro, Silvia [1 ]
Bouchemal, Kawthar [1 ]
Ponchel, Gilles [1 ]
机构：
[1] Univ Paris 11, Fac Pharm, UMR CNRS 8612, Inst Galien Paris Sud, F-92296 Chatenay Malabry, France
来源：
DRUG DISCOVERY TODAY | 2013年 / 18卷 / 1-2期
关键词：
SOLID LIPID NANOPARTICLES; CACO-2 CELL MONOLAYERS; POORLY SOLUBLE DRUGS; IN-VITRO EVALUATION; MULTIDRUG-RESISTANCE; POLY(AMIDOAMINE) DENDRIMERS; GASTROINTESTINAL ABSORPTION; MICROEMULSION FORMULATION; POLYMERIZED LIPOSOMES; ENHANCED ABSORPTION;
D O I：
10.1016/j.drudis.2012.08.007
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
In the past few years, the growth of nanometric size drug delivery systems (DDS) has burst into challenging innovations enabling real progresses to achieve oral delivery of anticancer drugs. DDS, such as polymeric nanoparticles, micelles, dendrimers and lipid-based formulations enable physico-chemical properties of cytotoxic agents to be improved and oral bioavailability to be enhanced. In this review we highlight current DDS used for the oral delivery of anticancer drugs.
引用
收藏
页码：99 / 104
页数：6
相关论文
共 50 条
  • [1] Liposomal Drug Delivery Systems and Anticancer Drugs
    Olusanya, Temidayo O. B.
    Ahmad, Rita Rushdi Haj
    Ibegbu, Daniel M.
    Smith, James R.
    Elkordy, Amal Ali
    MOLECULES, 2018, 23 (04):
  • [2] Oral Delivery of Anticancer Agents Using Nanoparticulate Drug Delivery System
    Mathur, Prateek
    Rawal, Shruti
    Patel, Bhoomika
    Patel, Mayur M.
    CURRENT DRUG METABOLISM, 2019, 20 (14) : 1132 - 1140
  • [3] Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs I. Formulation development
    Rao, Sri Priya Venkata Ramana
    Shao, Jun
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 362 (1-2) : 2 - 9
  • [4] Characterization of Particulate Drug Delivery Systems for Oral Delivery of Peptide and Protein Drugs
    Christophersen, Philip Carsten
    Fano, Mathias
    Saaby, Lasse
    Yang, Mingshi
    Nielsen, Hanne Morck
    Mu, Huiling
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (19) : 2611 - 2628
  • [5] FORMULATION OF ORAL MUCOSAL DRUG-DELIVERY SYSTEMS FOR THE SYSTEMIC DELIVERY OF BIOACTIVE MATERIALS
    PONCHEL, G
    ADVANCED DRUG DELIVERY REVIEWS, 1994, 13 (1-2) : 75 - 87
  • [6] Oral delivery of anticancer drugs: Challenges and opportunities
    Thanki, Kaushik
    Gangwal, Rahul P.
    Sangamwar, Abhay T.
    Jain, Sanyog
    JOURNAL OF CONTROLLED RELEASE, 2013, 170 (01) : 15 - 40
  • [7] Pharmaceutical nanotechnology for oral delivery of anticancer drugs
    Mei, Lin
    Zhang, Zhiping
    Zhao, Lingyun
    Huang, Laiqiang
    Yang, Xiang-Liang
    Tang, Jintian
    Feng, Si-Shen
    ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (06) : 880 - 890
  • [8] Novel nanogels as drug delivery systems for poorly soluble anticancer drugs
    Li, Na
    Wang, Jinli
    Yang, Xingguo
    Li, Lingbing
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2011, 83 (02) : 237 - 244
  • [9] Functionalized Graphene Oxide as Drug Delivery Systems for Platinum Anticancer Drugs
    Wei, Liying
    Li, Guo
    Lu, Taicheng
    Wei, Yiming
    Nong, Zhenzhen
    Wei, Mei
    Pan, Xin
    Qin, Qixiao
    Meng, Fayan
    Li, Xuehua
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 110 (11) : 3631 - 3638
  • [10] NANOSIZED DRUG DELIVERY SYSTEMS FOR PLATINUM-BASED ANTICANCER DRUGS
    Momekova, Denitsa B.
    Momekov, Georgi Ts.
    Koseva, Neli S.
    Peykov, Plamen T.
    Lambov, Nikolay G.
    PHARMACIA, 2013, 60 (03) : 21 - 45
12345